Switzerland-Taiwan Biotech Leaders Virtual Forum
瑞士台灣生技領導人線上論壇
Date:
Jul. 16th, 2020
Time:
10:00-11:00 AM (CEST, 歐洲中部夏令時間)
04:00-05:00 PM (Taiwan Time, 臺灣時間)
Venue: Zoom Virtual Meeting
Covid19 pandemic has created an unprecedented impact on the biotech industry around the globe. At the same time, such a crisis also provides opportunities to unite the industry and sparks extraordinary cooperation for finding therapeutics.
In this event, experts from Switzerland and Taiwan will sit together remotely and share their views on:
- The most critical impact of covid19 pandemic on biotech industries in Switzerland and Taiwan
- Innovative measures that the industry has taken during the crisis and the new normality
- Opportunities to collaborate and form a more resilient biotech alliance in the future
Invited Speakers
- Michael Altorfer
CEO, Swiss Biotech Association - Johnsee Lee 李鍾熙
Chairman, Taiwan Bio Industry Organization - John Tsai
Head of Global Drug Development and Chief Medical Officer, Novartis - Shiing-Jer Twu 涂醒哲
Chairman, Development Center for Biotechnology
Moderation
Thomas Brenzikofer
Co-Founder and Manager, DayOne, Basel Area Business & Innovation
Background image designed by kjpargeter / Freepik
Agenda
Time | Topics | Speakers |
---|---|---|
10:00 – 10:10 | Welcome Notes & Speakers Introduction | Dr. Linus Kao President Europe-Taiwan Biotech Association |
10:10 – 10:45 | Panel Discussion | Dr. Michael Altorfer CEO Swiss Biotech AssociationDr. Johnsee Lee 李鍾熙 Chairman Taiwan Bio Industry Organization Dr. med. John Tsai Dr. Shiing-Jer Twu 涂醒哲 Moderator: |
10:45 – 11:00 | Q&A |